News
Breast cancer experts and other HCPs disagree on treatment strategies for early BC
It’s challenging for some oncologists to keep up with the nuances of a rapidly changing field, said the author of new research.
News
‘Best’ for most APL patients: Chemo-free regimen
A chemo-free treatment regimen significantly improves survival over chemotherapy in patients with a rare, virulent leukemia, but those 50 and...
News
Hormone therapies still ‘most effective’ in treating menopausal vasomotor symptoms
Clinicians should individualize menopause care to each patient.
Article
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that affects the kidneys, lungs, brain, and heart, although it is not limited...
News
Risk threshold may help providers decide on rabies PEP
In the United States, rabies postexposure prophylaxis often is given without a comprehensive assessment that considers regional variances.
News
Immediate statin after acute stroke reduces disability
It was “safe, with no increased risk of bleeding, hepatotoxicity, or muscle toxicity.”
News
Profile of respiratory bacteria in children younger than 6 months
Researchers provide heretofore unreported contemporary data in a highly PCV13-immunized, community-based child population in the United States.
News
Antibiotic prophylaxis may lower SSIs in skin cancer surgery
There’s a lack of evidence from randomized clinical trials of the role of antibiotic prophylaxis in reducing SSI rates among patients undergoing...
News
Advising patients on AD treatment options: Expert pearls
Dupilumab dosing and dupilumab-associated facial redness and ocular disease, self-image issues, topical regimen adherence, and the quantification...
News
FDA panel unanimously endorses lecanemab for Alzheimer’s
An intravenous infusion targeting amyloid-beta, lecanemab received accelerated FDA approved earlier in 2023 for the treatment of early Alzheimer’s...